The Global eConsent In Healthcare Market Size is valued at 402.15 million in 2022 and is predicted to reach 996.61 million by the year 2031 at a 9.90% CAGR during the forecast period for 2023-2031.
Consent is a critical procedure in clinical trials involving communication, discussion, and agreement between participants and researchers. Participation in the trial is not feasible without consent. eConsent in Healthcare refers to the electronic process of obtaining informed consent from patients or participants in various healthcare settings, particularly in clinical trials. It is a digital alternative to traditional paper-based consent forms, where participants give their voluntary permission to participate in a study or receive medical treatment after being informed about the study or procedure's purpose, risks, benefits, and other relevant information.
For many healthcare organizations, particularly smaller or resource-constrained ones, successfully implementing eConsent can take time and effort. The expertise and investments in technology that are required could be challenging.
Additionally, lack of interoperability can impede market expansion, resulting in inefficient procedures, data silos, and a disjointed patient consent process. However, eConsent quickens the consent procedure, saving time for patients and healthcare professionals, which helps the market grow. Creating national guidelines makes designing, getting regulatory clearance, and using eConsent strategies easier. Moreover, clinical trial consent is streamlined with eConsent, increasing productivity and lowering administrative costs.
It makes it possible to record data in real-time, monitor it remotely, and exchange documents more quickly, streamlining trial procedures and promoting market expansion. eConsent plays a crucial role in the ongoing digital transformation of the healthcare industry. The need for enhanced efficiency, precision, and patient involvement is the primary catalyst for the expanding acceptance of technology-driven solutions like eConsent.
- In October 2022, Veeva Systems released Veeva ePRO, a patient-centric digital trial innovation. The software helps patients’ complete assessments on mobile devices or web browsers and gives sponsors and clinical research sites real-time data. Study teams can utilise ePRO to transmit high-quality data across the clinical ecosystem for transparency and collaboration as part of a connected clinical trial platform.
- In July 2021, Castor introduced a scalable patient enrollment and electronic consent platform in order to improve patient access and shorten recruitment cycles. Participants who have an easy, transparent enrolling process know what is expected of them in the study.
Competitive Landscape:
Some of the major key players in the eConsent In Healthcare market are:
- Advarra
- Castor
- Climedo Health GmbH
- Сlinсapture
- Clinical ink
- EClinCloud (Shenzhen) Technology Co., Ltd
- EvidentIQ Group GmbH
- Eclipse
- eClinicalHealth
- Medrio
- Medable Inc.
- Magentus
- Obvio Health USA, Inc.
- Signant Health
- Sitero
- Suvoda LLC
- IQVIA
- Interlace Health
- YonaLink
- Y-Prime, LLC
- THREAD
- Veeva Systems
- Wellbeing Software
- Citadel Group
- Florence Healthcare; Concentric Health Ltd
- 5thPort, LLC
- Cloudbyz
- Calysta EM
- Interlace Health
- Thieme Compliance GmbH
Market Segmentation:
The eConsent In the Healthcare market is segmented based on platform, enrollment, and form. Based on product, the eConsent In the Healthcare market is segmented as cloud-based and web-based. By enrollment type, the market is segmented into on-site and remote. The market is segmented by enrollment type into general consent, general consent with specific denial(s), general denial with specific consent(s) and general denial.
Based On The Form Type, The General Consent Segment Is A Major Contributor To The eConsent In The Healthcare Market
The general consent category will hold a major share in the global eConsent In Healthcare market 2022. Electronic health records (EHRs) and health information exchange (HIE) systems, both readily available, make it easier to adopt broad consent, which in turn fuels market expansion. Research and data analysis have new directions thanks to general consent. Researchers can access a plethora of data for population health studies, epidemiological research, and clinical trials by acquiring broad consent from a broader pool of patients. This increases the scope of available research projects, hastens medical advancements, and enhances patient care.
Cloud-based Segment Witness Growth At A Rapid Rate
The cloud-based segment is projected to develop rapidly in the global eConsent In Healthcare market. Healthcare professionals, researchers, and patients can easily collaborate thanks to cloud-based eConsent technologies. Cloud-based eConsent solutions improve data security and privacy, resolve concerns and satisfy regulatory standards, build trust, and speed up market adoption. Remote access is made possible by cloud-based eConsent technologies, allowing patients to consent at any time, from any location. Remote capabilities simplify the consent procedure, lower geographical obstacles, and enhance patient comfort, ultimately spurring market expansion.
The North American eConsent In Healthcare Market Holds A Significant Revenue Share In The Region
The North America eConsent In the Healthcare market is expected to register a tremendous market share Regulations compliance, technical improvements, patient-centered care models, the prominence of research and clinical trials, integration with EHRs, and broader digital transformation activities in the healthcare industry all drive the market for eConsent in North America. In addition, the Europe regional market is projected to grow rapidly in the global eConsent In Healthcare market.
Autonomy and patient rights are highly valued in the European region. eConsent systems empower patients to participate actively in their healthcare choices by providing comprehensive data on treatment options, risks, and benefits. This facilitates informed decision-making and encourages patients to engage in their healthcare actively. The growing acceptance of eConsent solutions in Europe reflects a shift toward patient-centered care.
Global eConsent In Healthcare Market Report Scope:
|
Report Attribute |
Specifications |
|
Market size value in 2022 |
USD 402.15 Mn |
|
Revenue forecast in 2031 |
USD 996.61 Mn |
|
Growth rate CAGR |
CAGR of 10.78 % from 2023 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Billion, and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Platform, Enrollment, And Form |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
Veeva Systems; Wellbeing Software; a Citadel Group; Florence Healthcare; Concentric Health Ltd; 5thPort, LLC; Cloudbyz; Calysta EMR; Interlace Health; Thieme Compliance GmbH |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
